Varices are a common finding in patients with cirrhosis, and variceal bleeding is a severe complication. Despite the advances in diagnosis and therapy, mortality from acute variceal bleeding is still very high, about 25–35%, and it is the second cause of death in cirrhotic patients and Non-selective β-blockers given to cirrhotic patients without a previous history of variceal bleeding reduce the risk of first bleeding and mortality rate.